Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy Pharmaceutical Technology 10:48
STAT Plus: Eli Lilly dives into hair loss treatments with investment in AI startup Absci STAT 21:10 Wed, 24 Jun
Absci Corp Stock Rises 18% After Positive Phase 1 Data For AI-Designed Drug Candidate RTT News 16:23 Wed, 24 Jun
Absci Reports Encouraging Phase 1 Safety Data For ABS-201, Prices $100 Million Offering; Stock Up RTT News 13:05 Wed, 24 Jun
MindWalk (Nasdaq: Hyft) CEO Dr. Jennifer Bath to Join Absci (Nasdaq: Absi) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery Business Wire (Press Release) 14:04 Fri, 12 Jun
